These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 25683351)

  • 21. Increased circulating microRNA-155 as a potential biomarker for breast cancer screening: a meta-analysis.
    Wang F; Hou J; Jin W; Li J; Yue Y; Jin H; Wang X
    Molecules; 2014 May; 19(5):6282-93. PubMed ID: 24840899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive power of circulating miRNAs in detecting colorectal cancer.
    Zeng W; Tu Y; Zhu Y; Wang Z; Li C; Lao L; Wu G
    Tumour Biol; 2015 Apr; 36(4):2559-67. PubMed ID: 25527153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic Value of Fecal MicroRNAs for Colorectal Cancer: a Meta-Analysis.
    Wang C; Zhao K; Rong Q
    Clin Lab; 2015; 61(12):1845-53. PubMed ID: 26882806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of microRNAs as the novel biomarkers for colorectal cancer diagnosis: A meta-analysis.
    Zuo Z; Jiang Y; Zeng S; Li Y; Fan J; Guo Y; Tao H
    Pathol Res Pract; 2020 Oct; 216(10):153130. PubMed ID: 32853954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum microRNA-21 as a diagnostic marker for lung carcinoma: a systematic review and meta-analysis.
    Yang X; Guo Y; Du Y; Yang J; Li S; Liu S; Li K; Zhang D
    PLoS One; 2014; 9(5):e97460. PubMed ID: 24865991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
    Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
    Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of circulating microRNAs for nasopharyngeal cancer: a systematic review and meta-analysis.
    Wang Z; Chen W; Zhang Y; Xu L; Wang Q
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C173-8. PubMed ID: 25450278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
    Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis.
    Peng Q; Zhang X; Min M; Zou L; Shen P; Zhu Y
    Oncotarget; 2017 Jul; 8(27):44893-44909. PubMed ID: 28415652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection Performance of Circulating MicroRNA-210 for Renal Cell Carcinoma: a Meta-Analysis.
    Chen Y; Wang X; Zhu X; Shao S
    Clin Lab; 2018 Apr; 64(4):569-576. PubMed ID: 29739083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.
    Wu K; Li L; Li S
    Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential role of microRNA-126 in the diagnosis of cancers: A systematic review and meta-analysis.
    Yan J; Ma S; Zhang Y; Yin C; Zhou X; Zhang G
    Medicine (Baltimore); 2016 Aug; 95(35):e4644. PubMed ID: 27583885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
    Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
    J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood-Based Circulating MicroRNAs are Potential Diagnostic Biomarkers for Leukemia: Result from a Meta-Analysis.
    Xu LH; Guo Y; Zhang XL; Chen JJ; Hu SY
    Cell Physiol Biochem; 2016; 38(3):939-49. PubMed ID: 26938054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of HE4 in ovarian cancer: A meta-analysis.
    Huang J; Chen J; Huang Q
    Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():35-42. PubMed ID: 30317143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Accuracy of procalcitonin for diagnosis of sepsis in adults: a Meta-analysis].
    Chengfen Y; Tong L; Xinjing G; Zhibo L; Lei X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Sep; 27(9):743-9. PubMed ID: 26955701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Lv ZC; Fan YS; Chen HB; Zhao DW
    Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of microRNAs as biomarkers for cholangiocarcinoma.
    Liang Z; Liu X; Zhang Q; Wang C; Zhao Y
    Dig Liver Dis; 2016 Oct; 48(10):1227-32. PubMed ID: 27476468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the diagnostic value of various microRNAs in blood for colorectal cancer: a systematic review and network meta-analysis.
    Xu J; Pan L; Wu D; Yao L; Jiang W; Min J; Xu S; Deng Z
    BMC Cancer; 2024 Jun; 24(1):770. PubMed ID: 38926893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A meta-analysis of the value of circulating tumor cells in monitoring postoperative recurrence and metastasis of colorectal cancer.
    Wu J; Li Z; Zou J; Li L; Cui N; Hao T; Yi K; Yang J; Wu Y
    PLoS One; 2022; 17(9):e0274282. PubMed ID: 36121855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.